from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2395/-

LFCtreatmentdescriptionclass of inhibitor

0.322

Amikacinug/mL Amikacintranslation

-0.307

Cap5-10ug/mL Capreomycintranslation

-0.758

Rox10-50 ug/mL Roxithromycintranslation

0.040

SM2-5 ug/mL Streptomycintranslation

-1.203

Tet5-10 ug/mL Tetracyclinetranslation

1.048

Rif0.2-5ug/mL Rifampicintranscription

1.981

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.190

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.951

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.344

CPZ10-50 ug/mL Chlorpromazinerespiration

0.385

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.162

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.288

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.493

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.068

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.411

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.477

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.414

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.717

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.555

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.354

KCN5-20 ug/mL Potassium cyaniderespiration

-0.523

NaN30.2-2 mM Sodium aziderespiration

-0.293

Nigericin50 uM Nigericinrespiration

0.223

TRC10-150 ug/mL Triclosanrespiration

0.860

TRZ10-25 ug/mL Thioridazinerespiration

-0.789

Valinomycin0.5-10 uM Valinomycinrespiration

-0.811

ZnSO42 mM ZnSO4respiration

0.662

menadione6-10 ug/mL Menadionerespiration

0.562

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.249

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.792

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.077

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.690

NRP_1Non-replicating persistence stage 1dosRassociated

-0.004

Amp0.2mg/mL AmpicillincellWall

-0.540

Cephalexin20-100 ug/mL CephalexincellWall

0.349

Cerulenin0.32-5 ug/mL CerulenincellWall

0.295

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.061

EMB10-20 ug/mL EthambutolcellWall

-0.127

Eta12-40 ug/mL EthionamidecellWall

-0.403

INH0.2-0.4 ug/mL IsoniazidcellWall

0.458

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.123

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.279

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.017

BZA0.12 mg/mL BenzamidearomaticAmides

-0.241

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.915

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.524

H2O24 mM hydrogen peroxideDNAdamaging

0.704

Levo10 ug/mL LevofloxacinDNAdamaging

-0.588

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.172

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.637

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.657

UVUV-irradiationDNAdamaging

2.062

ARP41-4 ug/mL Antitubercular compound ARP4?

0.296

Antimycin12.5-50 ug/mL Antimycin A?

0.602

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.429

PA_110-50 ug/mL Antitubercular compound PA-1?

0.397

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.253

PA8240.2-2 ug/mL PA-824?

-1.089

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.122

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.501

Verapamil50 uM Verapamil?

1.196

mercaptoethanol2 mM 2-Mercaptoethanol?

0.514

methoxatin10-20 ug/mL Methoxatin?